A detailed history of Glenmede Trust CO Na transactions in Novo Nordisk A S stock. As of the latest transaction made, Glenmede Trust CO Na holds 295,430 shares of NVO stock, worth $25.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
295,430
Previous 300,573 1.71%
Holding current value
$25.8 Million
Previous $42.9 Million 18.01%
% of portfolio
0.17%
Previous 0.22%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $612,377 - $747,895
-5,143 Reduced 1.71%
295,430 $35.2 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $1.75 Million - $2.09 Million
14,253 Added 4.98%
300,573 $42.9 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $2.89 Million - $3.84 Million
28,256 Added 10.95%
286,320 $36.8 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $58,373 - $70,124
665 Added 0.26%
258,064 $26.7 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $13.8 Million - $30.4 Million
152,202 Added 144.68%
257,399 $23.4 Million
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $210,288 - $252,873
-1,589 Reduced 1.49%
105,197 $16.7 Million
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $131,058 - $172,951
-1,278 Reduced 1.18%
106,786 $14.5 Million
Q3 2022

Nov 16, 2022

SELL
$95.28 - $116.93 $258,589 - $317,348
-2,714 Reduced 2.45%
108,064 $10.8 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $3.13 Million - $3.69 Million
-30,308 Reduced 21.48%
110,778 $12.3 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $1.03 Million - $1.24 Million
11,034 Added 8.48%
141,086 $15.7 Million
Q4 2021

Feb 15, 2022

SELL
$95.88 - $117.08 $381,698 - $466,095
-3,981 Reduced 2.97%
130,052 $14.6 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $1.72 Million - $2.17 Million
-20,320 Reduced 13.16%
134,033 $12.9 Million
Q2 2021

Aug 16, 2021

SELL
$67.66 - $84.76 $341,750 - $428,122
-5,051 Reduced 3.17%
154,353 $12.9 Million
Q1 2021

May 18, 2021

SELL
$67.06 - $75.82 $1.09 Million - $1.23 Million
-16,205 Reduced 9.23%
159,404 $10.7 Million
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $134,424 - $155,275
2,104 Added 1.21%
175,609 $12.3 Million
Q3 2020

Nov 16, 2020

SELL
$63.69 - $70.22 $66,428 - $73,239
-1,043 Reduced 0.6%
173,505 $12 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $475,696 - $552,080
-8,126 Reduced 4.45%
174,548 $11.4 Million
Q4 2019

Feb 12, 2020

BUY
$49.86 - $58.26 $30,215 - $35,305
606 Added 0.33%
182,674 $10.6 Million
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $98,265 - $110,439
2,067 Added 1.15%
182,068 $9.41 Million
Q2 2019

Aug 13, 2019

BUY
$46.79 - $52.47 $44,590 - $50,003
953 Added 0.53%
180,001 $9.19 Million
Q1 2019

May 14, 2019

BUY
$46.36 - $52.63 $2,596 - $2,947
56 Added 0.03%
179,048 $9.36 Million
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $3.18 Million - $3.62 Million
-76,658 Reduced 29.99%
178,992 $8.24 Million
Q3 2018

Nov 15, 2018

BUY
$46.76 - $51.24 $3.48 Million - $3.81 Million
74,387 Added 41.04%
255,650 $12.1 Million
Q2 2018

Aug 15, 2018

SELL
$44.29 - $50.42 $4.67 Million - $5.31 Million
-105,407 Reduced 36.77%
181,263 $8.36 Million
Q4 2017

Feb 15, 2018

SELL
$47.53 - $53.73 $4.26 Million - $4.82 Million
-89,624 Reduced 23.82%
286,670 $15.4 Million
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $15.5 Million - $18.5 Million
376,294
376,294 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.